TLX has only trialed in 30 patients(excluding the current ph3 that hasn't reported)? So that leaves 195 from previous studies done many years ago and there should be data for them? My understanding is TLX didn't run a ph2 trial, they bought another company that brought with it old data?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6820 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.52 | 3500 | 1 |
View Market Depth
| Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |